SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Procter & Gamble Co – ‘10-Q’ for 9/30/02 – EX-11

On:  Thursday, 10/31/02, at 2:41pm ET   ·   For:  9/30/02   ·   Accession #:  80424-2-168   ·   File #:  1-00434

Previous ‘10-Q’:  ‘10-Q’ on 5/2/02 for 3/31/02   ·   Next:  ‘10-Q’ on 1/29/03 for 12/31/02   ·   Latest:  ‘10-Q’ on 4/19/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

10/31/02  Procter & Gamble Co               10-Q        9/30/02    4:47K

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report -- jas0210q                          22     81K 
 2: EX-11       Jas02-10-Q                                             1      7K 
 3: EX-12       Jas02-10-Q - Exhibit 12                                1      7K 
 4: EX-99       Jas02-10-Q - Certifications                            2      8K 


EX-11   —   Jas02-10-Q



[Enlarge/Download Table] EXHIBIT (11) THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Computation of Earnings Per Share Amounts in millions except per share amounts Three Months Ended September 30 2002 2001 --------------- -------------- BASIC NET EARNINGS PER SHARE ---------------------------- Net earnings $ 1,464 $ 1,104 Preferred dividends, net of tax benefit 32 32 -------------- -------------- Net earnings available to common shareholders $ 1,432 $ 1,072 ============== ============== Basic weighted average common shares outstanding 1,300.0 1,296.1 ============== ============== Basic net earnings per common share $ 1.10 $ 0.83 ============== ============== DILUTED NET EARNINGS PER SHARE ------------------------------ Net earnings $ 1,464 $ 1,104 Deduct preferred dividend impact on funding of ESOP 2 3 -------------- -------------- Diluted net earnings $ 1,462 $ 1,101 ============== ============== Basic weighted average common shares outstanding 1,300.0 1,296.1 Add potential effect of: Conversion of preferred shares 86.3 90.4 Exercise of stock options 21.0 14.3 -------------- -------------- Diluted weighted average common shares outstanding 1,407.3 1,400.8 ============== ============== Diluted net earnings per common share $ 1.04 $ 0.79 ============== ==============
Top
Filing Submission 0000080424-02-000168   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 6:33:29.1pm ET